A federal grand jury in Nevada has indicted a Henderson physician over an alleged $95 million scheme to bill Medicare for amniotic wound coverings applied to elderly patients, including people receiving hospice care, moving a spending scandal that has drawn federal scrutiny for two years into individual criminal court.
Stephen Dubin, 74, sole owner of Dubin Medical Consultants Inc., also known as Wound MD, faces one count of conspiracy to commit health care fraud and five counts of health care fraud. According to the Justice Department announcement, Medicare paid more than $54 million on the claims. He faces up to 10 years in prison on each count if convicted.
These are allegations. No conviction has occurred, and the defendant is presumed innocent. What is not in dispute is the category of product at the center of the case, and the fact that Medicare beneficiaries carried part of its cost.
Products Billed by the Square Inch
Skin substitutes are wound coverings, many derived from donated placental or amniotic tissue, used when chronic wounds such as diabetic foot ulcers or venous leg ulcers fail to heal with standard care. Used appropriately, they are legitimate clinical tools.
The problem was how Medicare paid for them. Under the old average sales price method, reimbursement was tied to a product's reported price, which created an incentive to bring high-priced products to market. Launch prices historically ran into the thousands of dollars per square centimeter.
The clinical evidence has never matched the price. Multiple products have not been shown to heal common wounds better than conventional dressings, which is why the spending curve alarmed federal auditors long before any indictment. The HHS Office of Inspector General warned in a 2025 review of major concerns about fraud, waste, and abuse in Part B skin substitute payments.
Allegations Centered on Patients Least Able to Object
The specific conduct alleged is what separates this case from a billing dispute. Prosecutors say the physician received illegal kickbacks, bribes and rebates from two allograft distributors, with some payments structured to look like legitimate rebate agreements.
According to the indictment, those payments induced the grafts to be applied without regard to medical necessity, including on infected wounds, on wounds that were not responding to allograft treatment, without first completing the conservative wound care Medicare requires, and in quantities far exceeding the size of the wounds themselves. Some patients were in hospice care. To conceal the lack of medical necessity, prosecutors say he falsified patient medical records and billed on the basis of inflated invoices rather than the prices he actually paid.
Assistant Attorney General Colin M. McDonald of the Justice Department's National Fraud Enforcement Division said in a statement that the indictment exposes "a scheme driven by greed, not medicine." First Assistant United States Attorney Sigal Chattah of the District of Nevada said "Healthcare fraud is not a victimless crime," according to a Las Vegas television station's report.
The Cost Beneficiaries Already Absorbed
This is the part that reaches ordinary households. Medicare Part B is funded partly through monthly premiums paid by every beneficiary, so a spending category that inflates by billions raises what seniors pay whether or not they ever received the product.
CMS has documented that spending rose from $256 million to over $10 billion between 2019 and 2024, a nearly 40-fold increase, while the number of patients receiving the products only doubled. MedicalDaily previously reported on how that billing pattern affected Part B premiums. That earlier coverage focused on premiums and the payment loophole. This development is different: prosecutors are now naming a physician and describing what allegedly happened to specific patients at the bedside.
The payment system has since been restructured. A rule effective January 1, 2026 replaced the average sales price approach with a flat rate of $127.28 per square centimeter for most skin substitutes, and CMS has projected that the change will cut gross Part B spending on these products by roughly 90 percent. That projection has not yet been confirmed by final full-year data. Enforcement, meanwhile, addresses conduct that occurred before the fix.
Steps Families and Beneficiaries Can Take Now
Patients who received wound care do not need to assume they were harmed, and no one should stop treatment for a chronic wound because of a fraud case. Chronic wounds that go untreated can become infected and lead to amputation.
The most useful action is checking paperwork. Beneficiaries and family caregivers should read the Medicare Summary Notice for wound care services, looking for treatments on dates when no appointment occurred, repeated applications of grafts, providers whose names are unfamiliar, or charges out of proportion to the care received. Suspected fraud can be reported to the HHS Office of Inspector General at 1-800-HHS-TIPS.
Families managing a relative's wound care can also ask a treating clinician direct questions: whether standard wound care has been tried and documented, what the graft is expected to accomplish, how many applications are planned, and what the product costs Medicare. Those questions are appropriate and are not an accusation.
The case now moves through federal court in Nevada, where an arraignment and trial schedule will be set. MedicalDaily will report the case's progress and any further indictments.
The bottom line: the newest confirmed development is a criminal indictment naming a physician over $95 million in alleged wound care billing; the people most affected are Medicare beneficiaries who received these products, and everyone who pays a Part B premium; and the central uncertainty is that the allegations remain unproven.
Frequently Asked Questions
What are the charges? A federal grand jury indicted a Henderson, Nevada physician on one count of conspiracy to commit health care fraud and five counts of health care fraud tied to $95 million in Medicare billing for amniotic wound allografts.
Has anyone been convicted? No. These are allegations, and the defendant is presumed innocent unless proven guilty.
What is a skin substitute? A wound covering, often made from donated placental or amniotic tissue, used for chronic wounds that have not healed with standard care.
Do these products work? They have legitimate uses, but several products have not been shown to heal common wounds better than conventional dressings, which is part of why the spending drew federal scrutiny.
How does this affect people who never received one? Medicare Part B is funded partly by beneficiary premiums, so inflated spending in any category can raise costs across the program.
What should Medicare beneficiaries check? Review Medicare Summary Notices for wound care charges, unfamiliar providers, or services on dates when no appointment took place. Report suspected fraud to 1-800-HHS-TIPS.
Should patients stop wound care treatment? No. Untreated chronic wounds can become infected and lead to serious complications. Patients with questions should raise them with their treating clinician.
